Maria Espanol Mendez, MD
Pediatric Hematology-Oncology · Metairie, LANPI 1417302332
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $7,014 with a category attached, or 85.5%. HEMA Biologics, LLC accounts for 85.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $6,077 and has fallen 95.8% since, to $257 in 2025.
Across 21 payments — averaging $333.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- HEMA Biologics, LLC$6K
- Novo Nordisk$534
- BD$157
- Servier Pharmaceuticals LLC$98
- Genentech USA, Inc.$77
- Octapharma USA, Inc.$51
- plus $96 from 4 others
What the payments were for
- Consulting fees$6,00086%
- Grants$4306%
- Food & beverage$5848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| HEMA Biologics, LLC | 2 | $6,000 |
| Novo Nordisk | 6 | $534 |
| BD | 1 | $157 |
| Servier Pharmaceuticals LLC | 5 | $98 |
| Genentech USA, Inc. | 1 | $77 |
| Octapharma USA, Inc. | 1 | $51 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Chiesi USA, Inc. | 1 | $24 |
| Sobi, Inc | 1 | $17 |
| CSL Behring | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SevenFact$6,000
- HemoSphere$157
How this compares
$7,014 in reported general payments places this provider in the 70th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $59,820 |
| Warfarin Sodium | 37 | $329 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Metairie
- Corey FalconMetairie$104K
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.